The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model

[1]  Chia-Ron Yang,et al.  (N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo. , 2018, Journal of medicinal chemistry.

[2]  P. Hof,et al.  Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies , 2016, Biomolecules.

[3]  Jing Zhang,et al.  Tripchlorolide Attenuates β-amyloid Generation via Suppressing PPARγ-Regulated BACE1 Activity in N2a/APP695 Cells , 2016, Molecular Neurobiology.

[4]  J. Viña,et al.  Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease. , 2015, Free radical biology & medicine.

[5]  Anil Kumar,et al.  A review on Alzheimer’s disease pathophysiology and its management: an update , 2015, Pharmacological reports : PR.

[6]  Chun Cheng,et al.  Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation , 2015, Neurobiology of Aging.

[7]  K. Heese,et al.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease , 2016, Molecular Neurobiology.

[8]  Abbas Ali Mahdi,et al.  Therapeutics of Alzheimer's disease: Past, present and future , 2014, Neuropharmacology.

[9]  J. Chern,et al.  Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease. , 2013, Journal of medicinal chemistry.

[10]  A. Kakita,et al.  Brain expression level and activity of HDAC6 protein in neurodegenerative dementia. , 2013, Biochemical and biophysical research communications.

[11]  O. Schlüter,et al.  Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease , 2012, EMBO molecular medicine.

[12]  L. Petrucelli,et al.  Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation , 2012, Human molecular genetics.

[13]  A. Bush,et al.  GSK-3 in Neurodegenerative Diseases , 2011, International journal of Alzheimer's disease.

[14]  A. Kurz,et al.  Novel insights for the treatment of Alzheimer's disease , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  K. Ashe,et al.  Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.

[16]  Jesús Avila,et al.  GSK3: A possible link between beta amyloid peptide and tau protein , 2010, Experimental Neurology.

[17]  P. Dolan,et al.  Histone deacetylase 6 interacts with the microtubule‐associated protein tau , 2008, Journal of neurochemistry.

[18]  F. Sánchez‐Madrid,et al.  HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. , 2008, Trends in cell biology.

[19]  B. Allinquant.  Faculty Opinions recommendation of A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. , 2008 .

[20]  F. Alt,et al.  Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally , 2008, Molecular and Cellular Biology.

[21]  D. Selkoe,et al.  A Critical Function for β-Amyloid Precursor Protein in Neuronal Migration Revealed by In Utero RNA Interference , 2007, The Journal of Neuroscience.

[22]  Michael Ruse,et al.  Mechanisms and Models , 2007 .

[23]  Cam Patterson,et al.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.

[24]  K. Leroy,et al.  Increased level of active GSK‐3β in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration , 2007, Neuropathology and applied neurobiology.

[25]  N. Rosen,et al.  An acetylation site in the middle domain of Hsp90 regulates chaperone function. , 2007, Molecular cell.

[26]  J. Lucas,et al.  Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegeneration , 2006, Neurobiology of Aging.

[27]  Q. Tian,et al.  Endogenous overproduction of β-amyloid induces tau hyperphosphorylation and decreases the solubility of tau in N2a cells , 2006, Journal of Neural Transmission.

[28]  James Bradner,et al.  Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90 , 2005, Journal of Biological Chemistry.

[29]  Minoru Yoshida,et al.  HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. , 2005, Molecular cell.

[30]  N. Shahani,et al.  Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. , 2005, Biochimica et biophysica acta.

[31]  I. Grundke‐Iqbal,et al.  Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations* , 2004, Journal of Biological Chemistry.

[32]  P. Atadja,et al.  Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. , 2003, Cancer research.

[33]  M. Robin,et al.  Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells , 2003, The Journal of cell biology.

[34]  Akihiko Takashima,et al.  Chaperones increase association of tau protein with microtubules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Li-Huei Tsai,et al.  Cdk5: one of the links between senile plaques and neurofibrillary tangles? , 2003, Journal of Alzheimer's disease : JAD.

[36]  J. Lucas,et al.  FTDP-17 Mutations in tau Transgenic Mice Provoke Lysosomal Abnormalities and Tau Filaments in Forebrain , 2001, Molecular and Cellular Neuroscience.

[37]  K. Imahori,et al.  Exposure of rat hippocampal neurons to amyloid β peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β , 1996, Neuroscience Letters.

[38]  I. Grundke‐Iqbal,et al.  Dephosphorylation of Alzheimer Paired Helical Filaments by Protein Phosphatase-2A and −2B (*) , 1995, The Journal of Biological Chemistry.

[39]  K. Imahori,et al.  Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Takashima.  Tau protein I is essential for amyloid β-protein iduced neurotoxicity , 1993 .

[41]  K. Johnson.  An Update. , 1984, Journal of food protection.